
Alzheimer’s New Infusions - KisunlaⓇ and LeqembiⓇ: A Groundbreaking Treatment for Cognitive Decline
CNS proudly offers KisunlaⓇ and LeqembiⓇ, FDA-approved infusions that slow cognitive decline in early-stage Alzheimer’s patients. Our luxurious spa infusion suite provides a relaxing experience while our expert team ensures top tier neurological care.
Apr 15th, 2025